DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment

.

Source: Epigenetics - January 12, 2020 Category: Genetics & Stem Cells Authors: Federica Sarno Angela Nebbioso Lucia Altucci Source Type: research